Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
WHTC 1450 Holland· 2 hours agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 3 hours agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 9 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 19 hours agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Levi Strauss, Pfizer, Goldman Sachs and Cigna Face Challenges from Conservative Shareholders
National Center for Public Policy Research· 2 hours agoProposals Target Donations to Radical Causes, Net Zero Plans and DEI Programs Washington, D.C. – Shareholder activists with the National Center for Public Policy Research’s Free Enterprise Project ...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 4 hours agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Sigma Planning Corp Lowers Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoSigma Planning Corp lowered its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 52.6% in the fourth quarter, according to its most recent 13F filing with the SEC ...
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE)
Benzinga· 1 day agoLoading... Loading... Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 18 unusual ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 1 day agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
Pfizer Inc. (PFE) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 1 day agoPfizer Inc.’s recent filing unveils that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share, ...